Multi-Omics Analysis of Hippocampus in Rats Administered Trimethyltin Chloride

Douaa Zakaria1,2, Tomoki Yamashita1, Yohei Kosugi3

  • 1DMPK&Modeling, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi, 2-Chome, Fujisawa, Kanagawa, 251-8555, Japan.

Neurotoxicity Research
|March 17, 2025
PubMed

Insights

Trimethyltin chloride (TMT) causes neurodegeneration by damaging the central nervous system (CNS). Longitudinal multi-omic data revealed early changes in chemokine, apoptosis, and TNF signaling pathways preceding neuro-axonal damage markers.

Area of Science:

  • Neuroscience
  • Toxicology
  • Molecular Biology

Background:

  • Trimethyltin chloride (TMT) is a known neurotoxicant that induces central nervous system (CNS) damage and neurodegeneration.
  • Understanding the temporal dynamics of TMT-induced neurotoxicity is crucial for developing effective interventions.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying TMT-induced neurotoxicity using a longitudinal multi-omic approach.
  • To identify key biological pathways and molecular players involved in TMT-induced neurodegeneration over time.

Main Methods:

  • Utilized transcriptomics and proteomics on rat hippocampus samples collected at multiple time points (12, 24, 48, 72, 168 hours) post-TMT administration.
  • Analyzed plasma Neurofilament Light (NfL) levels as a biomarker for neuro-axonal damage.
  • Performed pathway enrichment analysis and gene-disease association studies.

Main Results:

  • Plasma NfL levels significantly increased at 72 and 168 hours, indicating neuro-axonal damage.
  • Differential gene expression in chemokine, apoptosis, and TNF signaling pathways was observed starting at 48 hours, preceding NfL elevation.
  • 11 Alzheimer's disease-related proteins were identified, suggesting the role of post-translational modifications in TMT neurotoxicity.

Conclusions:

  • Longitudinal omics studies combined with biomarker analysis provide valuable insights into neurotoxicant-induced neurodegeneration.
  • Early molecular changes in specific signaling pathways precede observable neuro-axonal damage, offering potential therapeutic targets.
  • Findings contribute to a better understanding of TMT neurotoxicity and may inform future therapeutic strategies.

Related Concept Videos